The Anti-inflammatory TIPE2 Is an Inhibitor of the Oncogenic Ras

Molecular Cell

Volumn 45, Issue 5, 2012, Pages 610-618

  Gus Brautbar, Yael ^a   Johnson, Derek ^a   Zhang, Li ^b   Sun, Honghong ^a   Wang, Peng ^a   Zhang, Shirley ^a   Zhang, Lining ^b   Chen, Youhai H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EXOCYST; PROTEIN KINASE B; RAL PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 L2; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARCINOGENESIS; CELL ASSAY; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BINDING SITES; BINDING, COMPETITIVE; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MIDDLE AGED; NIH 3T3 CELLS; ONCOGENE PROTEIN V-AKT; RAL GTP-BINDING PROTEINS; RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR;

MUS;

EID: 84862827148     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.01.006     Document Type: Article

References (38)

1. Carmody R.J., Ruan Q., Palmer S., Hilliard B., Chen Y.H. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 2007, 317:675-678.
2. Chien Y., White M.A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 2003, 4:800-806.
3. Chien Y., Kim S., Bumeister R., Loo Y.M., Kwon S.W., Johnson C.L., Balakireva M.G., Romeo Y., Kopelovich L., Gale M., et al. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127:157-170.
4. Feig L.A. Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol. 2003, 13:419-425.
5. Ferro E., Trabalzini L. RalGDS family members couple Ras to Ral signalling and that's not all. Cell. Signal. 2010, 22:1804-1810.
6. Gonzalez-Garcia A., Pritchard C.A., Paterson H.F., Mavria G., Stamp G., Marshall C.J. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 2005, 7:219-226.
7. Hamad N.M., Elconin J.H., Karnoub A.E., Bai W., Rich J.N., Abraham R.T., Der C.J., Counter C.M. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 2002, 16:2045-2057.
8. Hao Y., Wong R., Feig L.A. RalGDS couples growth factor signaling to Akt activation. Mol. Cell. Biol. 2008, 28:2851-2859.
9. He B., Guo W. The exocyst complex in polarized exocytosis. Curr. Opin. Cell Biol. 2009, 21:537-542.
10. Jin R., Junutula J.R., Matern H.T., Ervin K.E., Scheller R.H., Brunger A.T. Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase. EMBO J. 2005, 24:2064-2074.
11. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
12. Kong L., Ge B.X. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res. 2008, 18:745-755.
13. Li D., Song L., Fan Y., Li X., Li Y., Chen J., Zhu F., Guo C., Shi Y., Zhang L. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Immunol. 2009, 133:422-427.
14. Lim K.H., Baines A.T., Fiordalisi J.J., Shipitsin M., Feig L.A., Cox A.D., Der C.J., Counter C.M. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005, 7:533-545.
15. Lim K.H., O'Hayer K., Adam S.J., Kendall S.D., Campbell P.M., Der C.J., Counter C.M. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 2006, 16:2385-2394.
16. Martin T.D., Samuel J.C., Routh E.D., Der C.J., Yeh J.J. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res. 2011, 71:206-215.
17. Moskalenko S., Henry D.O., Rosse C., Mirey G., Camonis J.H., White M.A. The exocyst is a Ral effector complex. Nat. Cell Biol. 2002, 4:66-72.
18. Moskalenko S., Tong C., Rosse C., Mirey G., Formstecher E., Daviet L., Camonis J., White M.A. Ral GTPases regulate exocyst assembly through dual subunit interactions. J. Biol. Chem. 2003, 278:51743-51748.
19. Murai H., Ikeda M., Kishida S., Ishida O., Okazaki-Kishida M., Matsuura Y., Kikuchi A. Characterization of Ral GDP dissociation stimulator-like (RGL) activities to regulate c-fos promoter and the GDP/GTP exchange of Ral. J. Biol. Chem. 1997, 272:10483-10490.
20. Ou Y.H., Torres M., Ram R., Formstecher E., Roland C., Cheng T., Brekken R., Wurz R., Tasker A., Polverino T., et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 2011, 41:458-470.
21. Oxford G., Owens C.R., Titus B.J., Foreman T.L., Herlevsen M.C., Smith S.C., Theodorescu D. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res. 2005, 65:7111-7120.
22. Rangarajan A., Hong S.J., Gifford A., Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6:171-183.
23. Rosse C., Hatzoglou A., Parrini M.C., White M.A., Chavrier P., Camonis J. RalB mobilizes the exocyst to drive cell migration. Mol. Cell. Biol. 2006, 26:727-734.
24. Sale E.M., Sale G.J. Protein kinase B: signalling roles and therapeutic targeting. Cell. Mol. Life Sci. 2008, 65:113-127.
25. Smith S.C., Oxford G., Baras A.S., Owens C., Havaleshko D., Brautigan D.L., Safo M.K., Theodorescu D. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin. Cancer Res. 2007, 13:3803-3813.
26. Sowalsky A.G., Alt-Holland A., Shamis Y., Garlick J.A., Feig L.A. RalA function in dermal fibroblasts is required for the progression of squamous cell carcinoma of the skin. Cancer Res. 2011, 71:758-767.
27. Spaargaren M., Bischoff J.R. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc. Natl. Acad. Sci. USA 1994, 91:12609-12613.
28. Spiczka K.S., Yeaman C. Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration. J. Cell Sci. 2008, 121:2880-2891.
29. Sugihara K., Asano S., Tanaka K., Iwamatsu A., Okawa K., Ohta Y. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat. Cell Biol. 2002, 4:73-78.
30. Sun H., Gong S., Carmody R.J., Hilliard A., Li L., Sun J., Kong L., Xu L., Hilliard B., Hu S., et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008, 133:415-426.
31. Tian X., Rusanescu G., Hou W., Schaffhausen B., Feig L.A. PDK1 mediates growth factor-induced Ral-GEF activation by a kinase-independent mechanism. EMBO J. 2002, 21:1327-1338.
32. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 1996, 15:810-816.
33. Ward Y., Wang W., Woodhouse E., Linnoila I., Liotta L., Kelly K. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell. Biol. 2001, 21:5958-5969.
34. White M.A., Vale T., Camonis J.H., Schaefer E., Wigler M.H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 1996, 271:16439-16442.
35. Wolthuis R.M., Bauer B., van 't Veer L.J., de Vries-Smits A.M., Cool R.H., Spaargaren M., Wittinghofer A., Burgering B.M., Bos J.L. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 1996, 13:353-362.
36. Wolthuis R.M., de Ruiter N.D., Cool R.H., Bos J.L. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 1997, 16:6748-6761.
37. Xi W., Hu Y., Liu Y., Zhang J., Wang L., Lou Y., Qu Z., Cui J., Zhang G., Liang X., et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol. Immunol. 2011, 48:1203-1208.
38. Zhang X., Wang J., Fan C., Li H., Sun H., Gong S., Chen Y.H., Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat. Struct. Mol. Biol. 2009, 16:89-90.